Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
381.00
458.00
628.00
676.00
554.00
522.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
381.00
458.00
628.00
676.00
554.00
522.00
Expenditure (Ex Depriciation)
Stock Adjustments
48.00
0.00
-59.00
-58.00
-2.00
4.00
Raw Materials Consumed
248.00
318.00
460.00
444.00
344.00
333.00
Power & Fuel Cost
34.00
35.00
45.00
38.00
25.00
28.00
Employee Cost
61.00
61.00
52.00
50.00
38.00
29.00
Operating Expenses
22.00
15.00
16.00
13.00
11.00
5.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
7.00
2.00
7.00
10.00
6.00
5.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
10.00
10.00
10.00
10.00
8.00
13.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
447.00
464.00
551.00
522.00
443.00
437.00
Operating Profit (PBDIT) excl Other Income
-66.00
-5.00
76.00
154.00
111.00
85.00
Other Income
5.00
5.00
13.00
10.00
7.00
11.00
Operating Profit (PBDIT)
-60.00
0.00
89.00
164.00
119.00
97.00
Interest
36.00
25.00
20.00
9.00
4.00
12.00
Profit before Depriciation and Tax
-97.00
-25.00
68.00
155.00
114.00
84.00
Depreciation
43.00
36.00
33.00
34.00
25.00
23.00
Profit Before Taxation & Exceptional Items
-140.00
-61.00
34.00
121.00
89.00
61.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-140.00
-61.00
34.00
121.00
89.00
61.00
Provision for Tax
-6.00
-14.00
9.00
31.00
24.00
13.00
Profit After Tax
-134.00
-46.00
25.00
89.00
65.00
47.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
275.00
326.00
303.00
216.00
154.00
111.00
Profit Available for appropriations
140.00
279.00
329.00
306.00
219.00
158.00
Appropriations
140.00
279.00
329.00
306.00
219.00
158.00
Equity Dividend (%)
0.00%
0.00%
15.00%
15.00%
15.00%
15.00%
Earnings Per Share
-68.71
-23.93
13.04
45.87
33.23
24.29
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -16.78% vs -27.06% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -1,019.76% vs -107.75% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 45.47% vs 21.78% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -187.29% vs -283.21% in Mar 2024
Compare Profit and Loss Results of Astec Lifescienc
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
381.00
828.00
-447.00
-53.99%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
381.00
828.00
-447.00
-53.99%
Expenditure (Ex Depriciation)
Stock Adjustments
48.00
-15.00
63.00
420.00%
Raw Materials Consumed
248.00
474.00
-226.00
-47.68%
Power & Fuel Cost
34.00
35.00
-1.00
-2.86%
Employee Cost
61.00
53.00
8.00
15.09%
Operating Expenses
22.00
95.00
-73.00
-76.84%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
24.00
-17.00
-70.83%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
10.00
12.00
-2.00
-16.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
447.00
709.00
-262.00
-36.95%
Operating Profit (PBDIT) excl Other Income
-66.00
119.00
-185.00
-155.46%
Other Income
5.00
14.00
-9.00
-64.29%
Operating Profit (PBDIT)
-60.00
134.00
-194.00
-144.78%
Interest
36.00
4.00
32.00
800.00%
Profit before Depriciation and Tax
-97.00
129.00
-226.00
-175.19%
Depreciation
43.00
18.00
25.00
138.89%
Profit Before Taxation & Exceptional Items
-140.00
111.00
-251.00
-226.13%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-140.00
111.00
-251.00
-226.13%
Provision for Tax
-6.00
29.00
-35.00
-120.69%
Profit After Tax
-134.00
82.00
-216.00
-263.41%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
275.00
665.00
-390.00
-58.65%
Profit Available for appropriations
140.00
747.00
-607.00
-81.26%
Appropriations
140.00
747.00
-607.00
-81.26%
Equity Dividend (%)
0%
75%
-75.00
Earnings Per Share
-68.71
7.14
-75.85
-1,062.32%
Profit And Loss - Net Sales
Net Sales 381.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -16.78% vs -27.06% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -66.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1,019.76% vs -107.75% in Mar 2024
Profit And Loss - Interest
Interest 36.70 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 45.47% vs 21.78% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax -134.71 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -187.29% vs -283.21% in Mar 2024






